Raffa Wealth Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Raffa Wealth Management's HAE Position: Q3 2026 in Review
Raffa Wealth Management opened a new position in Haemonetics (HAE) in Q3 2026: 1 share worth $105. The stake represents ﹤0.01% of the portfolio and ranks #1380 among its holdings. This is a return to the name: Raffa Wealth Management previously reported a position in HAE as recently as Q4 2016.
Raffa Wealth Management first reported a position in HAE in Q4 2013 and has held it in 12 quarters since. The position peaked at $809 in Q1 2015. 361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Raffa Wealth Management held 1 share of Haemonetics worth $105 as of Q3 2026.
- Haemonetics was a new Raffa Wealth Management position in Q3 2026.
- Haemonetics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1380 holding.
- Raffa Wealth Management first reported a position in Haemonetics in Q4 2013 and has held it in 12 quarters since.
- Raffa Wealth Management's Haemonetics position peaked at $809 in Q1 2015.
- 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.